These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 19898570

  • 1. [Autoimmune hemolytic anemia].
    Berentsen S, Sundic T, Hervig T, Tjønnfjord GE.
    Tidsskr Nor Laegeforen; 2009 Nov 05; 129(21):2226-31. PubMed ID: 19898570
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Autoimmune hemolytic anemia].
    Karasawa M.
    Nihon Rinsho; 2008 Mar 05; 66(3):520-3. PubMed ID: 18326320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
    Sigler E, Shvidel L, Yahalom V, Berrebi A, Shtalrid M.
    Transfusion; 2009 Jul 05; 49(7):1370-4. PubMed ID: 19374728
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Delayed response to rituximab of cold agglutinin haemolytic disease].
    Calvo-Villas JM, Cuesta Tovar J, Carreter de Granda E, Sicilia Guillén F.
    An Med Interna; 2006 May 05; 23(5):224-8. PubMed ID: 16817700
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency.
    Wakim M, Shah A, Arndt PA, Garratty G, Weinberg K, Hofstra T, Church J.
    Am J Hematol; 2004 Jun 05; 76(2):152-5. PubMed ID: 15164382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transfusion therapy in autoimmune hemolytic anemia.
    Jefferies LC.
    Hematol Oncol Clin North Am; 1994 Dec 05; 8(6):1087-104. PubMed ID: 7860438
    [Abstract] [Full Text] [Related]

  • 14. [Autoimmune hemolytic anemia: diagnosis and management].
    Philippe P.
    Presse Med; 2007 Dec 05; 36(12 Pt 3):1959-69. PubMed ID: 17481848
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab for refractory childhood autoimmune hemolytic anemia.
    Motto DG, Williams JA, Boxer LA.
    Isr Med Assoc J; 2002 Nov 05; 4(11):1006-8. PubMed ID: 12489491
    [Abstract] [Full Text] [Related]

  • 18. Autoimmune hemolytic anemia: classification and therapeutic approaches.
    Sève P, Philippe P, Dufour JF, Broussolle C, Michel M.
    Expert Rev Hematol; 2008 Dec 05; 1(2):189-204. PubMed ID: 21082924
    [Abstract] [Full Text] [Related]

  • 19. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C.
    Haematologica; 2004 Sep 05; 89(9):ECR34. PubMed ID: 15377486
    [Abstract] [Full Text] [Related]

  • 20. Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia.
    Dussadee K, Taka O, Thedsawad A, Wanachiwanawin W.
    J Med Assoc Thai; 2010 Jan 05; 93 Suppl 1():S165-70. PubMed ID: 20364571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.